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Inositol phosphorylceramide (IPC), the major sphingolipid in the genus Leishmania but
not found in mammals, is considered a potentially useful target for chemotherapy against
leishmaniasis. Leishmania (Viannia) braziliensis is endemic in Latin America and causes
American tegumentary leishmaniasis. We demonstrated that IPCs are localized internally
in parasites, using a specific monoclonal antibody. Treatment with 5µMmyriocin (a serine
palmitoyltransferase inhibitor) rendered promastigotes 8-fold less infective than controls
in experimental hamster infection, as determined by number of parasites per inguinal
lymph node after 8 weeks infection, suggesting the importance of parasite IPC or
sphingolipid derivatives in parasite infectivity or survival in the host. IPC was isolated
from promastigotes of three L. (V.) braziliensis strains and analyzed by positive- and
negative-ion ESI-MS. The major IPC ions were characterized as eicosasphinganine
and eicosasphingosine. Negative-ion ESI-MS revealed IPC ion species at m/z 778.6
(d20:1/14:0), 780.6 (d20:0/14:0), 796.6 (t20:0/14:0), 806.6 (d20:1/16:0), and 808.6
(d20:0/16:0). IPCs isolated from L. (V.) braziliensis and L. (L.) major showed significant
differences in IPC ceramide composition. The major IPC ion from L. (L.) major, detected in
negative-ion ESI-MS at m/z 780.6, was composed of ceramide d16:1/18:0. Our results
suggest that sphingosine synthase (also known as serine palmitoyltransferase; SPT)
in L. (V.) braziliensis is responsible for synthesis of a long-chain base of 20 carbons
(d20), whereas SPT in L. (L.) major synthesizes a 16-carbon long-chain base (d16).
A phylogenetic tree based on SPT proteins was constructed by analysis of sequence
homologies in species of the Leishmania and Viannia subgenera. Results indicate that
SPT gene position in L. (V.) braziliensis is completely separated from that of members
of subgenus Leishmania, including L. (L.) major, L. (L.) infantum, and L. (L.) mexicana.
Our findings clearly demonstrate sphingoid base differences between L. (V.) braziliensis
and members of subgenus Leishmania, and are relevant to future development of more
effective targeted anti-leishmaniasis drugs.
Keywords: antibody, ceramide, phosphoinositide, mass spectrometry, sphingolipid, eicosasphinganine,
eicosasphingosine
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INTRODUCTION
Leishmaniasis is a group of diseases caused by protozoan
parasites of the genus Leishmania. The prevalence of
leishmaniasis worldwide was recently estimated as 12 million
cases, with ∼1.5–2 million new cases per year (WHO, 2017).
The genus Leishmania is divided into two subgenera, Leishmania
(Leishmania) and Leishmania (Viannia), species of which
are responsible for various clinical pathologies (cutaneous,
mucocutaneous, and visceral leishmaniasis) and related
biological, molecular, and biochemical features (Shaw, 2011).
The metabolism of Leishmania sphingolipids (SLs) has
received considerable research attention during the past three
decades because of their biological relevance as structural cell
membrane components, and as bioactive compounds involved
in cell-cell recognition, cell adhesion, cell growth, and signal
transduction (Hakomori, 2004; Merrill, 2011; Adada et al., 2014).
Studies by several groups have revealed clear association between
SLs (and the enzymes responsible for their degradation) and
parasite infectivity and disease progression (Straus et al., 1993;
Zhang et al., 2003, 2010; Denny and Smith, 2004; Denny et al.,
2004; Tanaka et al., 2007; Pillai et al., 2012).
In mammals, the de novo biosynthetic pathway of
SLs, and consequent ceramide production, begins in the
endoplasmic reticulum (ER), with condensation by serine
palmitoyltransferase (SPT) of L-serine and palmitoyl-CoA
(16:0) to form 3-ketosphinganine, followed by reduction of
this intermediate to produce sphinganine (dihydrosphingosine,
which presents two hydroxy groups) in a reaction that involves
NADPH (Merrill, 2011; Markham et al., 2013). Sphinganine
is subsequently acylated by ceramide synthase (CerS) to form
dihydroceramide in the presence of n-acyl-CoA, followed
by production of ceramide catalyzed by a dihydroceramide
desaturase (Mullen et al., 2012). Evolutionary divergence has
been demonstrated in these steps of the de novo pathway,
and depends on the SL class and on the organism. SLs in
trypanosomatids and mammals are usually derived from long-
chain bases (LCBs) that contain two hydroxyl groups, and
are denoted by the letter “d” (di) followed by the number of
carbons in the chain. SLs in plants and fungi are derived from
dihydroxylated or trihydroxylated sphingoid bases, and are
denoted respectively by the letter “d” or “t.” Trihydroxylated
sphingoid bases in plants and fungi are later acylated to form
phytoceramide, a precursor of inositol phosphorylceramides
(IPCs) and glycosyl inositol phosphorylceramides (GIPCs)
(Markham et al., 2013; Del Poeta et al., 2014).
Abbreviations: BSA, bovine serum albumin; CerS, ceramide synthase; CID-MS,
collision-induced dissociation mass spectrometry; CM, chloroform/methanol; ER,
endoplasmic reticulum; ESI-MS, electrospray ionization mass spectrometry;
GIPC, glycosyl inositol phosphorylceramide; HPTLC, high performance
thin layer chromatography; IHW, isopropanol/hexane/water; IPC, inositol
phosphorylceramide; LCB, long-chain base; mAb, monoclonal antibody; NLS,
neutral loss scan; PBS, phosphate buffered saline; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PI, phosphatidylinositol; PL, phospholipid; PREIS,
Precursor íon scan; PS, phosphatidylserine; SL, sphingolipid; SM, sphingomyelin;
SPT, serine palmitoyltransferase.
In the SL biosynthetic pathway, ceramides or phytoceramides
synthesized in the ER are transferred to the Golgi apparatus,
where further modification of the primary hydroxyl group
results in formation of complex SLs, including glycosphingolipids
(GSLs), sphingomyelin (SM), IPCs, and GIPCs (Zhang and
Beverley, 2010; Zhang et al., 2010; Cingolani et al., 2016). SM
and GSLs are the major SLs in mammals, whereas IPC is the
major SL in Leishmania (Kaneshiro et al., 1986; Zhang and
Beverley, 2010; Zhang et al., 2010). In the parasitic protozoan
Trypanosoma brucei, IPC is found only in procyclic forms
(Guther et al., 2006; Fridberg et al., 2008), whereas in T. cruzi
IPC is synthesized as a precursor of GIPCs (Bertello et al.,
1995; Uhrig et al., 1996; Zhang et al., 2010). In fungi and
plants, there are two routes for biosynthesis of neutral and
phosphorylated SLs. Neutral GSLs are usually derived from LCBs
containing two hydroxy groups, whereas fungal IPCs and GIPCs
are usually derived from LCBs containing trihydroxy groups,
also known as phytosphingosine. Fungal monohexosylceramides
present additional ceramide modifications, such as methylation
of sphingoid base and hydroxylation of fatty acid (Suzuki
et al., 2008; Del Poeta et al., 2014; Guimarães et al., 2014).
In Leishmania, IPC was first identified in L. (L.) donovani
promastigotes (Kaneshiro et al., 1986), which express 2.1 × 108
molecules/cell, accounting for ∼10% of phospholipids. IPC was
detected subsequently in other Leishmania species (Zhang et al.,
2003; Denny et al., 2004; Hsu et al., 2007).
Leishmania SLs have been shown to be involved in parasite
morphology, infectivity, differentiation, and vesicular trafficking
(Zhang et al., 2003, 2007; Denny et al., 2004; Tanaka et al.,
2007; Castro et al., 2013). We demonstrated in 2006 that IPCs in
L. (V.) braziliensis promastigotes are present in fractions enriched
in membrane microdomains resistant to non-ionic detergent at
4◦C (Yoneyama et al., 2006). More recently, we showed that IPCs
in these promastigotes are essential for completion of cytokinesis,
and play a major role in cell proliferation (Castro et al., 2013).
IPCs are potentially useful targets for antiparasitic drugs, because
they play an essential role in parasite virulence and are not
expressed in mammalian cells. Studies using mass spectrometry
(MS) have shown that IPCs in L. (L.) mexicana (Singh et al., 1988)
and L. (L.) major (Hsu et al., 2007) contain mainly sphingoid
bases d16:1 and d16:0 with C18:0 fatty acid, whereas those in L.
(V.) braziliensis contain mainly C14:0 fatty acid (Yoneyama et al.,
2006).
In the present study, we used collision-induced dissociation
(CID) tandem MS with electrospray ionization (ESI) in both
negative-ion mode [M-H]− and positive-ion mode [M+H]+ to
characterize IPCs from L. (V.) braziliensis, one of the major
etiologic agents of cutaneous and mucocutaneous leishmaniasis
in South America. In cutaneous leishmaniasis, parasites spread
from the skin to the naso-oropharyngeal mucosa. The causative
factors for such mucosal dissemination and resulting mucosal
disease are poorly understood. Effective systemic treatment
of cutaneous leishmaniasis caused by L. (V.) braziliensis will
presumably reduce the risk of mucosal disease development.
We focused on characterization of IPCs from L. (V.) braziliensis
mainly because these molecules, and enzymes involved in
their specific biosynthetic pathways, are promising targets for
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anti-Leishmania drug development (Denny et al., 2006; Suzuki
et al., 2008; Young et al., 2012).
MATERIALS AND METHODS
Compounds
Stock solutions of 2 mM myriocin (a SL synthesis inhibitor)
(Sigma-Aldrich; St. Louis, MO, USA) were prepared in dimethyl
sulfoxide and stored at−70◦C for a maximum of 1 month.
Parasite Culture
Promastigotes of L. (V.) braziliensis strains
MHOM/BR/1987/M11272, MHOM/BR/2001/BA778 (from
Laboratório de Imunoparasitologia, Centro de Pesquisa
Gonçalo Muniz, Fundação Oswaldo Cruz, Bahia, Brazil) and
MHOM/BR/1975/M2903 were cultured at 23◦C by several
passages of log-phase parasites in Medium 199 supplemented
with 10% heat-inactivated fetal calf serum (Thermo Fisher
Scientific/ Life Technologies, Brazil), 2 mM L-glutamine (Sigma-
Aldrich), 0.02 mg ml−1 bovine hemin, 100 U ml−1 penicillin,
100 µg ml−1 streptomycin, and 2% sterile male human urine
(complete medium). The starting inoculum (0.4 × 107 cells
ml−1) consisted of parasites isolated from early stationary
phase. Parasites were collected either in log-phase or after 48 h
(stationary phase). L. (V.) major strain MRHO/SU/59/P (LV39)
was also cultured at 23◦C in complete Medium 199.
Parasite Infectivity
Leishmania (Viannia) braziliensis MHOM/BR/2001/BA778
promastigotes were cultured (starting inoculum 0.4 × 107
cells ml−1) in complete medium in the presence of myriocin
(5 µM) or equivalent vehicle concentration for 6 days. Cell
growth was estimated by counting cells with a hemocytometer
(Improved Double Neubauer). Parasite viability was determined
by SYTOX R© Blue staining (Thermo Fisher/ Life Technologies;
Carlsbad, CA, USA) as per the manufacturer’s protocol, and
shown to be >85% in control and myriocin-treated cultures.
Parasite cultures were washed with PBS, cells were resuspended
in PBS, and 1 × 106 parasites (0.05 ml) were inoculated
subcutaneously in footpads of female golden hamsters
(Mesocricetus auratus) (groups of four). Eight weeks after
inoculation (infection), inguinal lymph nodes were removed
and homogenized in 3 ml culture medium. Parasite suspension
from each node was plated in complete Medium 199, and
parasites were quantified by limiting dilution in 96-well plates
containing 120 µl well−1. Plates were kept at 23◦C for 7 days.
Parasite number (PN) per lymph node was estimated based on
the highest dilution at which parasites were detected after 7 days
(Lima et al., 1997), i.e., PN= highest dilution× 0.12 (ml well−1)
× 3 (ml inguinal lymph node suspension). Experiments were
performed in triplicate. All animal procedures were conducted
in accordance with the recommendations of the Guide for the
Care and Use of Laboratory Animals of the Brazilian National
Council of Animal Experimentation (www.cobea.org.br). The
protocol was approved by the Research Ethical Committee of
Federal University of São Paulo (Comite de Etica em Pesquisa da
Universidade Federal de Sao Paulo/Hospital Sao Paulo, Id# CEP
0226/10).
Indirect Immunofluorescence
Parasites were fixed with 2% formaldehyde in 10 mM phosphate
buffer, pH 7.2, containing 150 mM NaCl (PBS), for 10 min.
Some fixed cells were permeabilized with 0.1% saponin. Cells
were washed, resuspended in 1 ml PBS, and 100 µl of the
solution was added to coverslips pretreated with 0.1% poly-L-
lysine. Coverslips were blocked for 3 h with 0.1% gelatin in
PBS and for 1 h with 10% skimmed milk and 1% bovine serum
albumin (BSA) in PBS. Parasites were incubated sequentially with
primary antibody LST-1 (mouse IgM; reacts with Leishmania
IPC; Godoy et al., MS in prep) and SST-1 (IgG3; reacts with
L. braziliensis promastigote glycolipids) (Silveira et al., 2005)
for 1 h, washed with PBS, and incubated with goat anti-mouse
IgM (µ chain) conjugated to Alexa Fluor 647 or with goat
anti-mouse IgG (gamma chain) conjugated to Alexa Fluor 488
(Thermo Fisher) in a solution containing 1% BSA and 0.01
mM 4,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) in
PBS. Slides were examined under conventional or confocal
fluorescence microscopy with a Leica SP5 TS system with a
100x/1.44 oil objective. Images were acquired under optimal
instrument settings and processed by the ImageJ program (http://
rsbweb.nih.gov/ij/).
IPC Purification
Lipids were extracted from∼2× 108 promastigotes isolated from
either log phase or 48 h after stationary phase by homogenization
with isopropanol/hexane/water (IHW) (55:20:25, v/v/v) and
with chloroform/methanol (CM) (2:1, v/v) (Silveira et al.,
2005). Supernatants were collected and dried by rotary
evaporation. Samples were deacylated by alkaline hydrolysis
with methylamine, and lipid extracts were resuspended in 1.0
ml methanol/ methylamine 30%/n-butanol (4:3:1, v/v/v) and
incubated 3 h at 55◦C in a dry bath (Serunian et al., 1989). For
purification of IPC, the lipid fraction was resuspended in CM/
water (30:60:8, v/v/v; “solvent A”) and applied toDEAE-Sephadex
A-25 columns. Columns were washed with five volumes of
solvent A and then with five volumes of methanol, and IPCs were
eluted with five volumes of 0.05 M sodium acetate in methanol
(Toledo et al., 1995). The acidic fraction was dried, dialyzed
exhaustively against distilled water, and partitioned with one
volume of n-butanol saturated with water. The butanolic phase
was collected and analyzed by HPTLC (Merck) and ESI-MS. IPCs
were visualized on HPTLC as blue spots using Dittmer-Lester
reagent (Yoneyama et al., 2006).
ESI-MS
MS measurements were obtained using a triple-quadrupole
instrument (model 310, Varian Inc./Agilent Technologies) with
ESI source. Data acquisition was performed using the Varian MS
Workstation program, V. 6.9. Sample analysis was conducted in
positive-ion and negative-ion ESI modes with respective needle
voltages 5.8 and 5 kV (Guan et al., 2010). Non-targeted mass
scanning range was m/z 500–950, with capillary temperature
200◦C, drying gas pressure (N2) 20 psi, and nebulizing gas (N2)
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40 psi. Each MS2 individual ion fragmentation was optimized
with regard to capillary and collision energy to minimize
variations in relative ion abundance resulting from differences in
dissociation rates. The CID gas was argon at 2 mTorr. The inlet
system consisted of a direct infusion pump (Harvard Apparatus),
andmethanol/ water (8:2, v/v) with 5 mM ammonium formate as
mobile phase, flow rate 30 µl min−1. Precursor ion scan (PREIS)
for detection of ion containing phosphoinositol derivative m/z
259 (inositol monophosphate anion) and m/z 241 (inositol-1,2-
cyclic phosphate anion) was performed in negative ion mode
with capillary energy -110 V and collision energy 40 V. Typically,
20 scans were used for accumulation of non-targeted scan range,
and 30 scans for analysis of precursor ions. Ion characterization
was performed by CID in negative and positive ion mode with
collision energy 15, 30, or 45 V (Hsu et al., 2007).
Phylogenetic Inference of Serine
Palmitoyltransferase (SPT) Proteins
Phylogenetic analysis was performed using gene data from
SPT enzymes from many distinct species of the family
Trypanosomatidae: L. (L.) infantum, L. (L.) donovani, L. (L.)
mexicana, L. (L.) major, L. (V.) braziliensis, L. (V.) guyanensis,
L. (V.) panamensis, T. brucei, and T. cruzi CL Brener. Sequences
were chosen by homology search using BLAST software with
annotated yeast and/or human proteins as baits. Sequences were
retrieved from GenBank or GeneDB (TriTrypDB) (Table 1). ID
sequences used to construct the tree are shown in Table 1. Yeast
and human proteins were used as outgroup. Putative proteins
were aligned using the Sea View software program (V. 3.2) with
TABLE 1 | Proteins and GenBank/GeneDB accessions used for phylogenetic
studies.
Species Serine palmitoyl
transferase
SPT (LCB)
GenBank/GeneDB
accession ID
Leishmania
subgenus
L. (L.) infantum,
L. (L.) mexicana,
L. (L.) major
SPT
(L. major: whole, N and
catalytic)
LINJ_35_0320
LMXM_34_0320Lm
jF.35.0320
Viannia subgenus
L. (V.) braziliensis,
L. (V.) guyanensis,
L. (V.) panamensis
SPT
(L. braziliensis: whole,
N and catalytic)
LbrM.34.0360
CCM18812.1
LPMP_340300
Trypanosoma brucei SPT Tb10.70.3220
Trypanosoma cruzi SPT TcCLB.503453.100
Yeast
(Saccharomyces
cerevisiae)
LCB1
LCB2
AJS85732.1
NP_010347.1
Human SPT1,
SPT2,
SPT3
NP_006406.1
NP_004854.1
NP_060797.2
an embedded MUSCLE (Multiple Sequence Comparison by Log-
Expectation) program. Alignment was performed using default
parameters. The phylogenetic tree was inferred by Bayesian
methods using theMrBayes software program (V. 3.2.3) with tree
parameter optimization during generations. Bayesian inference
was made by placing the phylogenetic root halfway between the
two most divergent/ distant proteins (midpoint rooting). Data
were saved every 100 generations and run in four chains and two
runs. A Bayesian tree was inferred based on 1 × 107 generations
with burn-in = 75,000. Consensus trees were used to determine
posterior probability values. The generated consensus tree was
visualized using the Figtree software program (V. 1.4.2; http://
tree.bio.ed.ac.uk/software/figtree/).
Data Analysis
Quantitative data were analyzed by Student’s t-test, using
GraphPad Prism software program V. 5.0 (San Diego, CA,
USA). Differences between means were considered statistically
significant for p < 0.01. All experiments were performed in
triplicate.
RESULTS
Immunolocalization of L. (V.) braziliensis
IPCs
To determine whether IPCs are expressed on the Leishmania
surface, parasites were double-labeled with monoclonal
antibodies (mAbs) directed to L. (V.) braziliensis glycolipids
(mAb SST-1), and to Leishmania IPC (mAb LST-1).
Representative images from a z-stack confocal series are
shown in Figure 1. SST-1 (green) labels the parasite surface
(Figure 1A; arrows), and LST-1 (red) labels internal fluorescence
(Figure 1B; arrowheads). No co-localization was observed
between SST-1 and LST-1 (Figure 1C). These findings indicate
that no IPCs are localized on the parasite surface. An animation
of 29 confocal z-stack slices (Video 1, Supplemental Information)
shows differing focal planes of parasites labeled with mAb LST-1
(red), mAb SST-1 (green), and DAPI (blue).
Effect of Myriocin on L. (V.) braziliensis
Infectivity
We investigated the effect of myriocin on parasite infectivity,
in view of our previous observations that 5 µM myriocin
reduces L. (V.) braziliensis IPC expression, growth rate, and
cytokinesis (Castro et al., 2013). Golden hamsters were infected
subcutaneously via footpad with promastigotes treated (or not)
with 5 µM myriocin for 6 days. After 8 weeks, infection rate
was determined in inguinal lymph nodes by limiting dilution
assay. PN per lymph node was significantly reduced (8-fold)
for myriocin-treated parasites in comparison with controls
(Figure 2), suggesting that sphingosine derivatives (e.g., IPCs or
biosynthetic intermediates) play an important role in host cell
infection.
Characterization of L. (V.) braziliensis IPCs
Purified IPC fractions from parasites were characterized by
ESI-MS. Because IPC has a phosphate residue that is readily
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FIGURE 1 | Immunolocalization of L. (V.) braziliensis (BA778) IPCs and GIPLs. Parasites were permeabilized with saponin 0.1%, fixed, labeled with mAb LST-1
(directed to Leishmania IPC; red), mAb SST-1 (directed to L. (V.) braziliensis glycolipids; green), and DAPI (nuclei and kinetoplasts; blue), and analyzed by confocal
microscopy. (A–C) Representative optical section of focal plane showing intracellular labeling of IPC (arrowheads), and surface labeling of SST-1 (arrows). Scale bar:
5 µm.
FIGURE 2 | Parasite burden of inguinal lymph nodes of golden hamsters
infected subcutaneously via footpad with stationary growth phase of L. (V.)
braziliensis (BA778) promastigotes pretreated (or not) with 5 µM myriocin.
Nodes were removed after 8 weeks of infection, and parasite burden was
determined by limiting dilution as described in Materials and Methods.
*p < 0.05.
ionizable, ESI-MS in negative ion mode was the appropriate
method for quick detection of IPC ions. All IPC ions were
characterized by detection of inositol phosphate fragments atm/z
259, corresponding to inositol monophosphate anion (InsP), and
atm/z 241, corresponding to inositol-1,2-cyclic phosphate anion
(InsP-H2O). ESI-MS of [M-H]
− ions of IPC fractions purified
from three L. (V.) braziliensis strains (BA778, M2902, M11272)
were performed, and similar spectral profiles were observed for
all strains. In full scan of IPC fraction from negative-ion ESI-MS
of L. (V.) braziliensis (M11272), major ions were detected at m/z
778.6 and 780.6, and minor components were detected at m/z
796.6, 806.6, and 808.6 (Figure 3A). ESI-MS of [M-H]− ions of
L. (L.) major IPC fraction showed a distinctive profile: the major
IPC ion was at m/z 778.6, relative abundance of m/z 780.6 was
significantly reduced, and minor IPC ions were detected at m/z
796.6 and 806.6 (Figure 3C). In full scan spectra of IPC fractions
in positive-ion mode ESI-MS, corresponding protonated ions
were detected at m/z 780.6, 782.6, 798.6, 808.6, and 810.6 for
L. (V.) braziliensis, and at m/z 780.6, 782.6, 798.6, and 808.6 for
L. (L.) major (Figures 3B,D).
Characterization by ESI-MS/MS of L. (V.)
braziliensis IPC [M-H]− ions at m/z 778.6
and 780.6, and of [M+H]+ ions at m/z 780.6
and 782.6
To characterize the structures of individual IPC ions, CID was
performed in negative ion mode for confirmation of inositol
derivative ions, and in positive ion mode for characterization
of ceramide moiety. LCB ions give rise to well-established ion
signatures comprised of double dehydrated ions, e.g., m/z 292,
294, 236, and 238 correspond respectively to d20:1-, d20:0-,
d16:1-, and d16:0-LCB.
CID was performed for major IPC ions detected in L. (V.)
braziliensis and L. (L.) major (Hsu et al., 2007) by ESI-MS/MS
in negative-ion mode (Figures 4A–C) and positive-ion mode
(Figures 4D–I). By analysis of tandem MS product ions of
corresponding [M-H]− ions atm/z 778.6 from L. (V.) braziliensis
and L. (L.) major (Figures 4A,B) and at m/z 780.6 from
L. (V.) braziliensis (Figure 4C), phosphoinositol ion signatures
were confirmed by the presence of ions at m/z 259 (InsP) and
241 (InsP-H2O).
Ceramide moieties were characterized by CID in positive-
ion mode using various collision energies. MS/MS product ion
spectra of L. (V.) braziliensis [M+H]+ ions at m/z 780.6, using
collision energy of 15V, yielded expected fragments at m/z 762
(M-H2O), 520 (M-InsP), and 502 (M-InsP-H2O) (Figure 4D).
We also detected a fragment at m/z 292, the signature ion
of d20:1-LCB (LCB product after elimination of one water
molecule). Application of higher collision energy (45 V) for the
ion atm/z 780.6 (Figure 4G), in addition to fragments atm/z 520,
502, and 292, led to detection of spectral signature ions atm/z 252
and 228, corresponding to a 14:0-fatty acid acyl substituent (FAI
and II derivatives C16H30ON
+ and C14H30ON
+, respectively),
suggesting that this compound was d20:1/14:0-IPC. Figure S1, at
Supplemental Information, shows the structures of main MS/MS
products of L. (V.) braziliensis [M+H]+ ion atm/z 780.6.
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FIGURE 3 | ESI-MS spectra of [M-H]− and [M+H]+ ions of IPC purified from L. (V.) braziliensis (M11272) and L. (L.) major (stationary growth phase). (A,C) ESI-MS
spectra of [M-H]− ion of IPC fractions of L. (V.) braziliensis and L. (L.) major, respectively. (B,D) ESI-MS spectra of [M+H]+ ion of IPC fractions of L. (V.) braziliensis and
L. (L.) major, respectively.
FIGURE 4 | ESI-CID-MS/MS spectra of IPC fractions obtained from L. (V.) braziliensis (M11272) and L. (L.) major at stationary phase. (A,B) Negative-ion
ESI-CID-MS/MS spectra, m/z 778.6, from L. (V.) braziliensis and L. (L.) major, with collision energy 45 and 30 V, respectively. (C) Negative-ion ESI-CID-MS/MS spectra
of L. (V.) braziliensis, m/z 780.6, with collision energy 30 V. (D,E) Positive-ion ESI-CID-MS/MS spectra, m/z 780.6, from L. (V.) braziliensis (d20:1/14:0) and L. (L.) major
(d16:1/18:0), with collision energy 15 V. (F) Positive-ion ESI-CID-MS/MS spectra of L. (V.) braziliensis, m/z 782.6 (d20:0/14:0), with collision energy 15 V. (G,H)
Positive-ion ESI-CID-MS/MS spectra, m/z 780.6, from L. (V.) braziliensis (d20:1/14:0) and L. (L.) major (d16:1/18:0), respectively, with collision energy 30 V.
(I) Positive-ion ESI-CID-MS/MS spectra of L. (V.) braziliensis, m/z 782.6 (d20:0:1/14:0), with collision energy 30 V.
ESI-MS/MS spectra of L. (L.) major [M+H]+ ion atm/z 780.6,
using collision energies 15 and 30V, gave rise as expected to
ions atm/z 762 (M-H2O), 520 (M-InsP), and 502 (M-InsP-H2O)
(Figures 4E,H), as observed previously for L. (V.) braziliensis.
The ion profile, in terms of LCB and fatty acid composition,
was distinct from that of L. (V.) braziliensis. Ions were detected
at m/z 236 (indicating the presence of d16:1 sphingoid base),
and fragments at m/z 308 and 284 (FAI and II derivatives
C20H38ON
+ and C18H38ON
+, respectively), identifying the
18:0-fatty acyl substituent, as described by Hsu et al. (2007).
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FIGURE 5 | ESI-CID-MS/MS spectra of IPC fractions obtained from L. (V.) braziliensis (M11272) stationary growth phase. (A,C,E) Spectra of m/z 796.6 (t20:0/14:0),
806.6 (d20:1/16:0), and 808.6 (d20:0/16:0), respectively, in negative-ion mode with collision energy 15 V. (B,D,F) Spectra of m/z 798.6 (t20:0/14:0), 808.6
(d20:1/16:0), and 810.6 (d20:0/16:0), respectively, in positive-ion mode with collision energy 5 V.
ESI-MS/MS spectra of L. (V.) braziliensis [M+H]+ ion at
m/z 782.6 using collision energies 15 and 45 V (Figures 4F,I)
generated fragments at m/z 764 (M-H2O), 522 (M-InsP), 504
(M-InsP-H2O), 294 (spectral signature of d20:0-LCB), 252, and
228 (spectral signatures of 14:0-fatty acid acyl substituent) (FAI
and II derivatives, C16H30ON
+ and C14H30ON
+, respectively),
indicating that this compound is d20:0/14:0-IPC.
Characterization by ESI-MS/MS of
L. (V.) braziliensis IPC [M-H]− ions at m/z
796.6, 806.6, and 808.6, and of [M+H]+ ions
at m/z 798.6, 808.6, and 810.6
We also characterized minor IPC ions of L. (V.) braziliensis. ESI-
MS/MS spectra of [M-H]− ions at m/z 796.6, 806.6, and 808.6
are shown in Figures 5A,C,E. Inositol phosphate signature ions
at m/z 259 (InsP) and 241 (InsP-H2O) were detected in all IPC
ions.
Analysis of ESI-MS/MS spectra of the [M+H]+ ion at m/z
798.6 allowed us to characterize the ceramide moiety. Using
collision energy 45V (Figure 5B), the spectra gave rise to
ions at m/z 538 (M-InsP), 520 (M-InsP-H2O), 328, 310, 292
(characteristic products of phytosphingosine t20:0), 252, and 228
(spectral signatures of 14:0 fatty acid acyl substituent) (FAI and
II derivatives C16H30ON
+ and C14H30ON
+, respectively). These
findings suggest that this ion (m/z 798.6 in positive-ion mode)
corresponds to t20:0/14:0-IPC.
Analysis of ESI-MS/MS spectra of the [M+H]+ ion at m/z
808.6 using collision energy 45 V (Figure 5D) generated ions
at m/z 548 (M-InsP), 530 (M-InsP-H2O), 292 (characteristic
of sphingoid base d20:1), 280, and 256 (corresponding to fatty
acid 16:0 acyl substituent) (FAI and II derivatives C18H34ON
+
and C16H34ON
+, respectively), suggesting that this compound is
d20:1/16:0-IPC.
Analysis of ESI-MS/MS spectra of the [M+H]+ ion at m/z
810.6 using collision energy 45 V (Figure 5F) generated ions
at m/z 550 (M-InsP), 532 (M-InsP-H2O), 294 (characteristic
of d20:0), 280, and 256 (corresponding to fatty acid 16:0
acyl substituent) (FAI and II derivatives C18H34ON
+ and
C16H34ON
+, respectively), suggesting that this compound is
d20:0/16:0-IPC.
IPC proposed structures and positive- and negative-ion ESI-
CID-MS/MS fragments of IPC ions from L. (V.) braziliensis are
summarized in Table 2. In contrast to IPCs of L. major (Hsu
et al., 2007), those of L. (V.) braziliensis display predominantly
20-carbon LCBs (d20:1, d20:0, t20:0), and C14:0 and C16:0
fatty acids. Positive-ion ESI-CID-MS/MS of IPC ions from L.
(V.) braziliensis did not detect product ions related to d16:0
(m/z 238) or d16:1(m/z 236). Positive-ion ESI-CID-MS/MS of
L. (L.) major IPC ion at m/z 780.6 did not detect sphingoid
base product related to d20:1 (m/z 292) (Figure 4H, Table 2).
The same ESI-MS/MS fragment profile was observed for IPC
isolated from L. (V.) braziliensis strains M11272, BA778, and
M2903.
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TABLE 2 | Leishmania (V.) braziliensis IPC-related product ions (m/z) formed in negative- and positive ESI-MS/MS.
L. (V.) braziliensis L. (L.) major*
Sphingoid d20:1 d20:0 t20:0 d20:1 d20:0 d16:0
Fatty acid 14:0 14:0 14:0 16:0 16:0 18:0
[M-H]− [M+H]+ [M-H]− [M+H]+ [M-H]− [M+H]+ [M-H]− [M+H]+ [M-H]− [M+H]+ [M-H]− [M+H]+
M 778 780 780 782 796 798 806 808 808 810 778 780
M-Ins 616 618 644
M-Ins-H2O 598 600 616 598
InsP 259 259 259 259 259 259
InsP-H2O 241 241 241 241 241 241
M-H2O 762 764 762
M-InsP 520 522 538 548 550 520
M-InsP-H2O 502 504 520 530 532 502
LCBI product 328
LCBII product 292 294 310 292 294 236
LCBIII product 292
FAI derivative 252c 252 252 280e 280 308a
FAII derivative 228d 228 228 256f 256 284b
M, ion mass; Ins, inositol; InsP, inositol phosphate; LCBI, LCBII, and LCBIII products correspond respectively to LCB fragment, LCB fragment–H2O and LCB fragment–2H2O; FA, fatty
acid derivative.
*Major IPC ion detected in Leishmania (L.) major.
abFatty acid derivatives described by Hsu et al. (2007) as C20H38ON
+, and C18H38ON
+, respectively.
cC16H30ON
+.
dC14H30ON
+.
eC18H34ON
+.
fC16H34ON
+.
Phylogenetic Inference of SPT Proteins
SPT in L. (V.) braziliensis is responsible for synthesis of 20-carbon
LCB (d20), whereas L. (L.) major presents mainly 16-carbon LCB
(d16), and T. brucei and T. cruzi SLs present mainly 18-carbon
sphingoid bases (d18) (Uhrig et al., 1996; Richmond et al., 2010;
Vacchina et al., 2012). We therefore considered the possibility
that these differences are related to SPT sequence homology with
eitherT. cruzi orT. brucei.We used Bayesian inference to identify
clades composed of species-related proteins (Figure 6). The
SPT protein sequences belonged to different clades, presenting
specific SPT nodes and branches among trypanosomatid species.
Human and yeast LCB enzymes were more closely related to
each other, and were totally separated from T. brucei, T. cruzi,
and Leishmania enzymes. Leishmania SPT was subdivided into
two subgroups. The species of the Viannia subgenus (L. (V.)
braziliensis, L. (V.) guyanensis and L. (V.) panamensis) were
completely separated from those of the Leishmania subgenus (L.
(L.) infantum, L. (L.) mexicana, and L. (L.) major), and comprised
two distinct clades. SPTs of T. brucei and T. cruzi also represented
different clades.
In addition to whole-protein sequences of Leishmania SPTs,
we also analyzed N-terminal and catalytic portions of SPTs
of L. (V.) braziliensis and L. (L.) major to determine whether
sequence homologies refer specifically to the catalytic portion.
Phylogenetic results were similar for sequences of SPT whole
proteins, N-terminal regions, and catalytic regions (Figure 6),
indicating that SPT catalytic regions of Leishmania are not closer
or more similar to those of either humans or trypanosomes.
FIGURE 6 | Bayesian consensus phylogeny of SPT proteins. The phylogram
represents a consensus of 13 SPT sequences. The root was inferred using
midpoint rooting. Posterior probabilities exceeding 0.5 are shown in the
branches. The tree topology indicates that SPTs of members of Leishmania
subgenus Leishmania are separated from those of Leishmania subgenus
Viannia, and that SPTs of Leishmania species are separated from those of
Trypanosoma brucei and T. cruzi. The scale of the generated tree (see 0.8 bar)
represents the number of substitutions per sequence position. Accession
numbers of SPT sequences are shown in Table 1. N, N-terminal end of
protein sequence; cat, catalytic region of protein sequence.
DISCUSSION
IPCs are the predominant SLs in the genus Leishmania (Zhang
and Beverley, 2010), including the medically important species
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L. (V.) braziliensis (Yoneyama et al., 2006). Our confocal
microscopy studies using mAb LST-1 (directed to Leishmania
IPC) showed that IPCs and GIPLs are not co-localized in L.
(V.) braziliensis promastigotes; GIPLs are found on the parasite
surface whereas IPCs are localized internally. Labeling of IPCs
was observed only when parasites were permeabilized with 0.1%
saponin, confirming the internal localization of IPCs. Previous
studies have demonstrated the involvement of Leishmania SLs
in a variety of biological processes, including differentiation,
replication, trafficking, and virulence (Zhang et al., 2010). We
demonstrated previously that L. (V.) braziliensis promastigotes
treated with the SPT inhibitor myriocin displayed reduced IPC
accumulation and incomplete cytokinesis (Castro et al., 2013).
In the present study, we investigated the role of SLs in L.
(V.) braziliensis infectivity. Golden hamsters were infected by
subcutaneous footpad injection of promastigotes treated (or not)
with 5 µM myriocin for 6 days. After 8 weeks of infection, PN
was counted in inguinal lymph nodes, and found to be ∼8-fold
lower formyriocin-treated parasites in comparison with controls.
Our findings suggest that IPCs (and/or their intermediate SLs)
are important for L. (V.) braziliensis infectivity, for their survival
during the first few hours inside macrophages, for differentiation
to amastigotes, and for amastigote proliferation. We obtained
similar results in a previous study of L. (L.) amazonensis mouse
experimental infection, in which parasite burden was reduced by
infection of mouse footpads with promastigotes pretreated with
a different SL inhibitor: the IPC synthase inhibitor aureobasidin
A (Tanaka et al., 2007). Along the same line, an SPT subunit 2
knockout mutant of L. (L.) major displayed defective membrane
trafficking events in extracellular promastigotes, thus delaying
promastigote infection in BALB/c mice (Denny et al., 2004). In
this paper we demonstrated that IPC is present intracellularly
in leishmania, and as showed previously IPC is concentrated in
non-ionic detergent insoluble domains (Yoneyama et al., 2006),
the above findings and others suggest that synthesis of SLs in
parasites, and the final biosynthetic product (IPC), are involved
in vesicle formation, membrane trafficking, protein sorting, and
cytokinesis, and play important roles in parasite growth/survival
and hence in the establishment of infection. Thus, parasite SLs
and the related biosynthetic enzymes are potentially useful targets
in anti-parasite chemotherapeutic strategies. In a previous study,
we used gas chromatography/MS to show that IPCs of L. (V.)
braziliensis contain mainly C14:0 fatty acid (Yoneyama et al.,
2006), but did not determine IPC mass or sphingoid bases.
IPCs of L. (L.) major and L. (L.) donovani contain mainly
C18:0 fatty acids (Hsu et al., 2007; Zheng et al., 2010). In the
present study, we purified IPCs from three L. (V.) braziliensis
strains, isolated from patients living in different regions of
Brazil: reference strain MHOM/BR/1975/M2903 from a subject
in Pará (Northern Brazil), strain MHOM/BR/01/BA788 from
a cutaneous leishmaniasis patient in Bahia State (Northeastern
Brazil), and strain MHOM/BR/1987/M11272 from a cutaneous
leishmaniasis patient in Paraná State (Southern Brazil). IPC
molecules were detected by negative-ion ESI-MS, as described by
Hsu et al. (2007), who demonstrated that the detection threshold
for [M-H]− ion is 10 times lower than those for [M+H]+,
[H+Li]+, and [M-H+Li]+ ions. A tandem MS approach using
positive-ion MS/MS allowed us to determine the ceramide
structure of IPCs and discriminate among isomeric structures,
providing better understanding of the metabolic pathway of SLs
in L. (V.) braziliensis, and to identify novel IPC structures. The
major IPC ions detected by negative-ion ESI-MS were at m/z
778 and 780 for all three strains, regardless of whether ions were
isolated at logarithmic or stationary growth phase. These two
ions accounted for >70% of IPCs expressed in the parasites. In
negative-ion mode, the full scan profile of IPC fractions isolated
from the three strains showed ions at m/z 778.6, 780.6, 796.6,
806.6, and 808.6 (Figure 3A). Predominant ion at m/z 778.6
has also been described for IPCs purified from L. (L.) major
and L. (L.) donovani (Hsu et al., 2007; Zheng et al., 2010).
When ceramide moieties were characterized by positive-ion ESI-
MS/MS, clear differences were detected in comparison with IPCs
from L. (L.) major (Hsu et al., 2007) and L. (L.) donovani
(Kaneshiro et al., 1986). L. (V.) braziliensis IPC [M+H]+ ions
at m/z 780.6 and 782.6 displayed fragments at m/z 292 (20:1-
LCB), 294 (20:0-LCB), and 228 (C14:0-fatty acyl substituent).
IPC ions with the same mass in positive-ion mode (m/z 780
and 782) from L. (L.) major presented d16:1 and d16:0 LCBs,
respectively, with C18:0-fatty acid. IPCs are the major SLs in
Leishmania; these findings therefore suggest strongly that L. (V.)
braziliensis preferentially synthesizes sphingoid bases through
condensation of L-serine and stearoyl-CoA (18:0) to produce
d20:0 in LCBs and ceramide, whereas L. (L.) major and L.
(L.) donovani (subgenus Leishmania) preferentially synthesize
d16:0 sphingoid base through condensation of L-serine and
myristoyl-CoA (14:0) (Kaneshiro et al., 1986; Hsu et al., 2007). In
contrast, mammals preferentially express 18-carbon LCBs (d18:0
and d18:1) in ceramide, synthesized by SPT proteins (Pruett
et al., 2008; Merrill, 2011). Phylogenetic data for SPT of L. (V.)
braziliensis showed that the SPT protein sequence of L. (V.)
braziliensis is completely separated from those of species in the
Leishmania subgenus, suggesting that L. (V.) braziliensis and
the Leishmania subgenus species represent different clades. The
constructed trees suggest that genetic factors are involved in
SPT separation. More precise studies are needed to clarify this
issue. The two Leishmania subgenera may have differentiated at
different times, as evidenced by the SPT protein data, and this
separationmay be responsible for observed differences in enzyme
functions and specificities. The overall conclusion from the SPT
phylogenetic tree is that neither L. major nor L. braziliensis is
closer to T. cruzi or T. brucei. It appears that the common
SPT ancestor of L. braziliensis and L. major separated from the
Trypanosomatidae prior to the separation of Leishmania.
IPCs isolated from L. (V.) braziliensis vs. L. major, in
addition to differences in LCBs, show distinctive fatty acid
compositions. In L. (V.) braziliensis IPCs, the major fatty acid
is C14:0, and there are only trace amounts of fatty acid 16:0,
as detected in positive-ion mode ESI-MS/MS at m/z 808.6 and
810.6. In contrast, the major fatty acid in L. (L.) major and
L. (L.) donovani IPCs is stearic acid (C18:0) (Hsu et al., 2007;
Zheng et al., 2010). Our findings also suggest that different
Leishmania subgenera have differing CerS substrates. Members
of the Viannia subgenus, e.g., L. (V.) braziliensis, preferentially
use d20:0 and myristoyl-CoA (14:0) or palmitoyl-CoA (16:0),
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whereas members of the Leishmania subgenus, e.g., L. (L.) major
and L. (L.) donovani, preferentially use d16:0 and stearoyl-
CoA (18:0) (Hsu et al., 2007; Zhang and Beverley, 2010; Zhang
et al., 2010). Mammals, in contrast, preferentially use d18:0
and various acyl-CoAs (carbon chain length varying from 16 to
26 depending on the CerS; Levy and Futerman, 2010; Merrill,
2011).
The existence of Leishmania-specific IPCs suggests that these
parasitic microorganisms have a complete and functional SL
biosynthetic pathway (Denny et al., 2004; Zhang et al., 2010),
for which LCB synthase, CerS, IPC activities, and/or IPC
genes have been described (Zhang et al., 2003, 2007; Denny
et al., 2004, 2006; Tanaka et al., 2007; Castro et al., 2013;
Ramakrishnan et al., 2013; Mandlik et al., 2014). However,
enzyme activities for Leishmania are not yet characterized,
and so far are based on or inferred from the final SL
biosynthetic product: IPC ceramide structure. In regard to
other trypanosomatids, Figueiredo et al. (2012) reported that
TcCerS in T. cruzi preferentially uses dihydrosphingosine
base as sphingosine base and palmitoylCoA as substrate, and
Sevova et al. (2010) showed that specific SL synthases in T.
brucei, T. cruzi, and L. major transfer polar head groups
from phosphoglycerolipid donors to generate SM, ethanolamine
phosphorylceramide, and IPC using 6-((N-(7-nitrobenz-2-oxa-
1,3-diazol-4-yl)amino)hexanoyl)sphingosine C6-ceramide.
Future studies on Leishmania enzyme specificities in LCB
synthesis and concurrent ceramide synthesis will contribute to
the development of more effective drugs having high ligand
efficiency indices against L. (V.) braziliensis, L. (L.) major, or L.
(L.) donovani, but low (or zero) ligand efficiency to mammalian
host cells.
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